Effect of Kinesio Taping Combined With Postural Correction on Improving Tension-Type Headache Among University Students

August 26, 2026 updated by: Deraya University
This study aims to evaluate the effectiveness of combining Kinesio Taping (KT) with postural correction exercises and suboccipital muscle inhibition (SMI) in managing tension-type headaches (TTH) among university students. The intervention's impact on headache intensity, frequency, and functional limitations will be compared with a control group performing postural correction and SMI alone.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Tension-type headache (TTH) is a common primary headache associated with muscular tension, poor posture, and psychological stress. Physiotherapy interventions including deep neck flexor exercises, suboccipital muscle inhibition (SMI), and postural education have been shown to reduce pain and improve posture.

Kinesio Taping (KT) has been proposed as an adjunct that enhances proprioception, reduces muscle tension, and supports cervical alignment.

This randomized controlled trial will recruit 52 university students aged 18-25 years diagnosed with frequent episodic TTH according to ICHD-3 criteria. Participants will be randomly assigned to two groups:

Group A (Control): Postural correction + SMI Group B (Experimental): Kinesio Taping + Postural correction + SMI

Both groups will receive two treatment sessions per week for 4 weeks.

Assessments will be performed at baseline, after 4 weeks of treatment, and at a 1-month follow-up using validated measures for pain, frequency, and posture.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
52

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Menia Governorate
      • Minya, Menia Governorate, Egypt
        • Deraya university, faculty of physical therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • University students aged 18-25 years
  • Diagnosed with tension-type headache per ICHD-3 criteria
  • At least 10 headache episodes per month for >3 months
  • Pericranial muscle tenderness (suboccipital, temporalis, upper trapezius)
  • Craniovertebral angle < 50°

Exclusion Criteria:

  • Migraine or cluster headaches
  • Recent neck trauma or surgery
  • Skin allergy or sensitivity to tape
  • Current use of medications affecting pain perception Cervical radiculopathy or neurological deficits

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Postural Correction and Suboccipital Muscle Inhibition

Participants will receive a postural correction program consisting of:

Deep neck flexor strengthening exercises (chin tucks, progressive resistance) Suboccipital muscle inhibition (manual pressure to release muscle tension) Ergonomic and postural education for studying and daily activities Two sessions per week for 4 weeks.
Other: Postural Correction and Suboccipital Muscle Inhibition
Deep neck flexor exercises, suboccipital muscle inhibition, and ergonomic education performed twice weekly for four weeks.
Experimental: Kinesio Taping + Postural Correction and SMI

Participants will receive the same postural correction program as the control group with the addition of Kinesio Taping:

Kinesio Tape applied to cervical spine and upper trapezius to enhance proprioception and reduce strain.

Two sessions per week for 4 weeks.
Other: Kinesio Taping + Postural Correction and SMI
Same as the control program with addition of Kinesio Taping to cervical and trapezius muscles.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Headache Intensity
Time Frame: Baseline, 4 weeks post-intervention, 1-month follow-up
Measurement Tool: Visual Analog Scale (VAS) / Numeric Pain Rating Scale Self-reported headache pain intensity (0-10 scale).
Baseline, 4 weeks post-intervention, 1-month follow-up
Headache Frequency
Time Frame: Baseline, 4 weeks post-intervention, 1-month follow-up
Measurement Tool: Headache Diary Number of headache days per month recorded by participants.
Baseline, 4 weeks post-intervention, 1-month follow-up
Headache Impact
Time Frame: Baseline, 4 weeks post-intervention, 1-month follow-up

Measurement Tool: Headache Impact Test (HIT-6)

Description: Assesses the effect of headaches on daily life and function.
Baseline, 4 weeks post-intervention, 1-month follow-up

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Pressure Pain Threshold (PPT)
Time Frame: Baseline and 4 weeks post-intervention
Measurement Tool: Pressure Algometer Description: Measures pericranial muscle tenderness.
Baseline and 4 weeks post-intervention
Craniovertebral Angle (CVA)
Time Frame: Baseline and 4 weeks post-intervention

Measurement Tool: Goniometer / Digital Photogrammetry

Description: Quantifies forward head posture; increased angle indicates improvement.
Baseline and 4 weeks post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Deraya University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 10, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 10, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 9, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 9, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 17, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 28, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 26, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • DU-PT-KT-TTH-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings